Skip to main content
DGX logo
DGX
(NYSE)
Quest Diagnostics Incorporated
$227.90-- (--)
Loading... - Market loading

Quest Diagnostics Incorporated (DGX) Stock Price & Financial Analysis

Quest Diagnostics Incorporated Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$220.00 - $237.78
52-Week High$219.20
52-Week Low$165.30
Open$228.09
Volume3.75M
Average Volume (3M)921.75K
Market Cap23.50B
Shares Outstanding112.00M
P/E Ratio (TTM)22.90
Forward P/E20.15
Price to Sales (P/S)2.08
Price to Book (P/B)3.18
EV/EBITDA12.10
Revenue (TTM)11.28B
Net Income (TTM)1.02B
Free Cash Flow (TTM)1.33B
EPS (TTM)$9.10
Profit Margin9.08%
Operating Margin14.31%
Return on Equity (ROE)13.90%
Debt to Equity0.77
50-Day MA$199.77
200-Day MA$191.90
52-Week Change24.52%
Annual Dividend$3.32
Dividend Yield1.59%
Payout Ratio36.47%
Last Dividend Ex-DateJul 8, 2026

Frequently Asked Questions About Quest Diagnostics Incorporated

What is the current stock price for DGX?

As of the latest trading session, DGX stock trades at $227.90. The 52-week range is $165.30–$219.20, with a day range of $220.00–$237.78.

What is the P/E ratio for DGX?

Quest Diagnostics Incorporated's trailing P/E ratio is 22.9, meaning investors pay $22.9 for every $1 of annual earnings. The forward P/E is 20.1, reflecting analyst expectations for future earnings. Quest Diagnostics Incorporated operates in the Healthcare sector.

Does DGX pay dividends?

Yes, Quest Diagnostics Incorporated pays a 1.59% annual dividend yield ($3.32 per share). The payout ratio is 36.5%. The last ex-dividend date was 2026-07-08.

What do analysts recommend for DGX?

Based on 4 analysts, the consensus for DGX is Buy.

What is the market cap of DGX?

Quest Diagnostics Incorporated's market capitalization is $25.52B, classifying it as a large-cap company. Quest Diagnostics Incorporated operates in the Healthcare sector within the Diagnostics & Research industry.